|
|
|
市場調査レポート
ドラッグデリバリー市場：経口デリバリー
Drug Delivery Markets: Oral Delivery
|
Abstract
Since our last edition of this report in 2007, the oral drug delivery market
is the largest segment of the drug delivery market, and there' s no sign that
it is slowing down. With pharmaceutical companies increasingly turning to drug
delivery to extend the revenue-earning lifetime of their biggest products, and
seeking to tap into the growing elderly population that requires products with
a level of ease-of-use and cost benefit, it' s no surprise that the oral drug
delivery market is a $35 billion industry and expected to grow as much as ten
percent per year. Kalorama' s Drug Delivery Markets: Oral Delivery provides the
definitive break down of the market for oral delivery drug markets. The report
covers both the major technologies in oral delivery (controlled-release,
delayed release, pulsatile-release, taste-masked and microemulsion
formulations) and the products that use these delivery technologies.
In the reporting of market size and growth through 2013, Kalorama' s unique
analysis breaks out separates the value of the technology portion of the
market from the active ingriedient portion of the market, allowing for a
deeper understanding of the value of the market attributable to the delivery
technologies themselves.
This focused report provides information on the revenues for relevant
companies and provides information critical to assessing the opportunities
available in this market, including:
- Legacy Companies in Oral Delivery as well as Recent Entrants
- Current World Wide Revenue Across Product Categories and Future Forecasts
- Revenues by Combonent and by Component ( Pharmaceutical vs. Technology
portion of Revenue) Type of Delivery (Timed Release vs. Other)
- Challenges Faced by Oral-Delivery Technology Companies
- Success Stories and Pitfalls
- The Trends That are Expected to Lead to Global Growth
Kalorama' s trusted information-gathering process provides most accurate study
of the oral delivery drug market available today. Information and analysis
presented in this report is based on extensive interviews with senior
management of top companies in the industry. While major research literature
and government information is culled, information is corroborated and key
market insights originate from interviews with industry leaders.
Product managers, marketing managers, business development executives,
advertising agency or investment firm executives, and information and research
center librarians are among the individuals who will find this report on the
oral delivery drug market essential.
Table of Contents
Chapter One: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Oral Drug Delivery Market
- Oral Drug Delivery Technology Only Market
- Competitive and Market Analysis
Chapter Two: Introduction and Overview
- Scope of the Report
- Methodology
- History of Oral Drug Delivery
- Phases of Drug Action
- Barriers to Oral Drug Delivery
- Controlled-Release/Sustained-Release
- Delayed Release and Modified Release
- Fast Dissolving
- Taste-Masked
- Pulsatile Release
- Microemulsion and Others
Chapter Three: Key Trends and Demographics
- The Elderly
- Regulatory Environment
- Patent Protection and Extension
- Earlier Involvement
- Consolidation
- Proprietary Product Development
- Implications for Generic and Over-the-Counter Products
- Pharmaceutical Formulation
Chapter Four: New Developments
- Macromolecule Delivery
- Delivery of Hydrophobic Drugs
- Other Delivery Solutions
Chapter Five: Market Size and Growth
- The Total Oral Drug Delivery Market
- Oral Delivery Technology Only Market
Chapter Six: Competitive Analysis
Chapter Seven: Company Profiles
- ALZA Corporation
- Biovail Corporation
- Elan Corporation, plc
- Emisphere Technologies, Inc.
- Ethypharm
- KV Pharmaceutical
- Labopharm, Inc.
- Penwest Pharmaceutical Company
- Purdue/MundiPharma/Napp Group
- SkyePharma PLC
- Watson Pharmaceuticals, Inc.
- Chapte Eight: Companies in Brief
- Alkermes, Inc.
- Astellas Pharma US
- CIMA Labs, Inc. Division of Cephalon
- DepoMed, Inc.
- Eurand, Inc.
- Galenix
- Intelgenx Technologies Corp
- Kos Pharmaceuticals, Inc.
- Lifecycle Pharma
- MicroDose Therapeutics, Inc.
- Scolr Pharma
- Xcelience
Appendix: Company Directory
List of Exhibits
Chapter One: Executive Summary
Chapter Two: Introduction and Overview
- Table 2-1: Selected Types of Oral Solid Preparations
- Table 2-2: Sequence of Drug Action
Chapter Three: Key Trends and Demographics
- Table 3-1: World Population by Age Group 2006-2013
- Figure 3-1: World Population by Age Group 2006-2013
- Table 3-2: Recent Consolidations in the Drug Delivery Market
Chapter Four: New Developments
Chapter Five: Market Size and Growth
- Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and
Pharmaceuticals Revenues and Growth Rate 2006-2013
- Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery
Technology and Pharmaceuticals 2006-2013
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug
Delivery Technologies by Type (Timed Release, Other) 2006-2013
- Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing
Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug
Market Share by Type 2006-2013
- Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by
Pharmaceutical vs Drug Delivery Components 2006-2013
- Table 5-5: The Worldwide Market for Oral Drug Delivery Systems
Distribution of Revenue by Pharmaceutical vs Delivery Technology Components
2006-2013
- Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of
Revenue by Pharmaceutical vs. Delivery Technology Component 2006, 2010
Chapter Six: Competitive Analysis
- Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company,
Proprietary Technology, Approved Products)
|
 |
